The Next Generation Accountable Care Organization model reduced gross Medicare spending for calendar years 2016 to 2018 by $349 million (0.9%) without increasing preventable hospitalizations or readmissions, according to findings released last week by the Centers for Medicare & Medicaid Services. Lower spending on professional services, skilled nursing facilities and other post-acute care contributed to the spending reductions, which may reflect participants’ investment in SNF networks, improved coordination and care transitions and substitution for higher-cost settings, the agency said.

Participants in the model can choose varying levels of financial risk, and receive financial incentives and care management tools to improve health outcomes and lower spending for an assigned Medicare fee-for-service population.

Net Medicare spending for CYs 2016-2018 rose by $118 million (0.3%) after accounting for shared savings and other incentive payments. CMS recently extended the five-year model through 2021 due to the COVID-19 pandemic. For additional results from the first three performance years, see the full evaluation report.

Related News Articles

Headline
The AHA Jan. 31 commended Sens. Bill Cassidy, R-La., Catherine Cortez Masto, D-Nev., John Cornyn, R-Texas., and Michael Bennet, D-Colo., on draft legislation…
Headline
The White House Office of Management and Budget Jan. 29 rescinded a memo it issued two days earlier directing federal agencies to temporarily pause federal…
Headline
An analysis by KFF released Jan. 28 found that Medicare Advantage insurers made nearly 50 million prior authorization determinations in 2023. The finding…
Headline
The White House Office of Management and Budget late Jan. 27 issued a memo directing federal agencies to temporarily pause federal grants, loans and other…
Headline
The AHA Jan. 27 voiced support for the Centers for Medicare & Medicaid Services proposed rule on policy and technical changes to Medicare Advantage and…
Headline
The Department of Health and Human Services Jan. 17 announced 15 Medicare Part D drugs selected for the latest round of price negotiations. Negotiations will…